ACC.26 Día 2 (Parte 1)
En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este segundo día en el ACC 2026 de Nueva Orleans. 1. Efficacy And Safety Of Sotatercept In Combined Post- And Pre-capillary Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction: Results From The Phase 2 Cadence Trial 2. Controlled Trial of High-Risk Coronary Intervention With Percutaneous Left Ventricular Unloading (CHIP-BCIS3) 3. A Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina- ORBITA-CTO Trial 4. Mavacamten in Symptomatic Adolescent Patients With Obstructive Hypertrophic Cardiomyopathy: Results From the Phase 3 Scout-HCM Trial
Embed this episode
No transcript yet.